Following the SEC's monitoring and examination of Bitazza operations, it was found that the company has significant deficiencies in critical systems related to the operation of digital asset business
16, 2018. Resolutions were passed to allow the company to conduct the following matters: 1. To give approval to the Company to enter into related transactions to rent or rent out immovable properties
Arrangement, Operating Systems and Providing Services of Securities and Derivatives Intermediaries dated 6 September 2556, the SEC hereby issues the following regulations: Clause 1 In this Notification
__________________ By virtue of Section 9 and Section 49 of the Derivatives Act B.E. 2546 (2003) , the Securities and Exchange Commission hereby issues the following regulations: Clause 1 In this Notification: (1)3
__________________ By virtue of Section 9 and Section 49 of the Derivatives Act B.E. 2546 (2003), the Securities and Exchange Commission hereby issues the following regulations: Clause 1 In this Notification: (1)3
Section 49 of the Derivatives Act B.E. 2546 (2003), the Securities and Exchange Commission hereby issues the following regulations: Clause 1 In this Notification: (1)3 “derivatives broker” means a person
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000
. 4) B.E. 2551 (2008), the Capital Market Supervisory Board hereby issues the following regulations: Clause 1 The Notification of the Capital Market Supervisory Board No. Tor Thor. 7/2557 Re: Rules
following table. (Unit: Million Baht) Q2/2016 Q2/2017 Y-O-Y Change Increase/(Decrease) Note Sales Revenue 213.2 196.4 (7.9%) The company's sales revenue for Q2/2017 was THB 196.4 mn and classified from the
Market Supervisory Board under Section 6 of the Derivatives Act (No. 2) B.E. 2551 (2008) hereby issues the following regulations: Clause 1 In this Notification: “ derivatives broker ” means a person